UGGC Avocats advised Tridek on the deal. Tridek-One, a biotech start-up specialized in the research and development of CD31 agonists to restore immune balance, in its...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here